{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:54:12Z","timestamp":1768877652972,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.hlc.2018.08.027","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T18:00:47Z","timestamp":1537898447000},"page":"57-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Sudden Death Risk-Stratification in 2018\u20132019: The Old and the New"],"prefix":"10.1016","volume":"28","author":[{"given":"Sarah","family":"Zaman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey J.","family":"Goldberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramesh","family":"Kovoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.hlc.2018.08.027_bib0005","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.hlc.2018.08.027_bib0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.hlc.2018.08.027_bib0015","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators","volume":"335","author":"Moss","year":"1996","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.hlc.2018.08.027_bib0020","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","article-title":"A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators","volume":"341","author":"Buxton","year":"1999","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.hlc.2018.08.027_bib0025","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1056\/NEJMoa043938","article-title":"Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both","volume":"352","author":"Solomon","year":"2005","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.hlc.2018.08.027_bib0030","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1161\/CIRCULATIONAHA.116.026075","article-title":"Sudden cardiac death in patients with ischemic heart failure undergoing coronary artery bypass grafting: results from the STICH randomized clinical trial (Surgical Treatment for Ischemic Heart Failure)","volume":"135","author":"Rao","year":"2017","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hlc.2018.08.027_bib0035","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.110.940619","article-title":"Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both","volume":"122","author":"Pouleur","year":"2010","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.hlc.2018.08.027_bib0040","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa041489","article-title":"Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction","volume":"351","author":"Hohnloser","year":"2004","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.hlc.2018.08.027_bib0045","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1056\/NEJMoa0901889","article-title":"Defibrillator implantation early after myocardial infarction","volume":"361","author":"Steinbeck","year":"2009","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.hlc.2018.08.027_bib0050","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1056\/NEJM199711273372201","article-title":"Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators","volume":"337","author":"Bigger","year":"1997","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.hlc.2018.08.027_bib0055","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/euhj.2000.2316","article-title":"Long-term recovery of left ventricular function after primary angioplasty for acute myocardial infarction","volume":"22","author":"Ottervanger","year":"2001","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.hlc.2018.08.027_bib0060","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.0000012350.99718.AD","article-title":"Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT)","volume":"105","author":"Bansch","year":"2002","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.hlc.2018.08.027_bib0065","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0735-1097(03)00297-3","article-title":"Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia\u2013AMIOVIRT","volume":"41","author":"Strickberger","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.hlc.2018.08.027_bib0070","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.hlc.2018.08.027_bib0075","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2018.08.027_bib0080","article-title":"Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis","author":"Beggs","year":"2017","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.hlc.2018.08.027_bib0085","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.116.026056","article-title":"Implantable cardioverter-defibrillator for nonischemic cardiomyopathy: an updated meta-analysis","volume":"135","author":"Golwala","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.08.027_bib0090","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.hrthm.2017.10.036","volume":"15","author":"Kusumoto","year":"2018","journal-title":"Heart Rhythm"},{"issue":"5","key":"10.1016\/j.hlc.2018.08.027_bib0095","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/jce.13192","article-title":"Mortality effect of ICD in primary prevention of nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"28","author":"Luni","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"1","key":"10.1016\/j.hlc.2018.08.027_bib0100","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.ajkd.2013.12.009","article-title":"Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials","volume":"64","author":"Pun","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.hlc.2018.08.027_bib0105","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2017.8462","article-title":"Long-term outcomes associated with implantable cardioverter defibrillator in adults with chronic kidney disease","author":"Bansal","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"19","key":"10.1016\/j.hlc.2018.08.027_bib0110","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1161\/CIRCULATIONAHA.117.028829","article-title":"Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with nonischemic systolic heart failure","volume":"136","author":"Elming","year":"2017","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.hlc.2018.08.027_bib0115","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1540-8167.2005.00224.x","article-title":"Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction","volume":"16","author":"Zareba","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"7","key":"10.1016\/j.hlc.2018.08.027_bib0120","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1540-8167.2008.01129.x","article-title":"Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial","volume":"19","author":"Russo","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"16","key":"10.1016\/j.hlc.2018.08.027_bib0125","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/archinternmed.2009.255","article-title":"Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials","volume":"169","author":"Ghanbari","year":"2009","journal-title":"Arch Intern Med"},{"issue":"13","key":"10.1016\/j.hlc.2018.08.027_bib0130","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0195-668X(03)00191-X","article-title":"Out-of-hospital cardiac arrest\u2014the relevance of heart failure. The Maastricht Circulatory Arrest Registry","volume":"24","author":"Gorgels","year":"2003","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.hlc.2018.08.027_bib0135","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jacc.2004.06.029","article-title":"Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community","volume":"44","author":"Chugh","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hlc.2018.08.027_bib0140","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jacc.2005.11.045","article-title":"Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study","volume":"47","author":"Stecker","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hlc.2018.08.027_bib0145","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1540-8167.2012.02407.x","article-title":"Low rate of secondary prevention ICDs in the general population: multiple-year multiple-source surveillance of sudden cardiac death in the Oregon Sudden Unexpected Death Study","volume":"24","author":"Havmoeller","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"6","key":"10.1016\/j.hlc.2018.08.027_bib0150","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jacc.2008.08.077","article-title":"The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention","volume":"53","author":"Costantini","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hlc.2018.08.027_bib0155","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/eurheartj\/ehn537","article-title":"Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction","volume":"30","author":"Huikuri","year":"2009","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.hlc.2018.08.027_bib0160","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.hrthm.2010.07.019","article-title":"Electrophysiology-guided defibrillator implantation early after ST-elevation myocardial infarction","volume":"7","author":"Kumar","year":"2010","journal-title":"Heart Rhythm"},{"issue":"23","key":"10.1016\/j.hlc.2018.08.027_bib0165","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.113.007497","article-title":"Sudden cardiac death early after myocardial infarction: pathogenesis, risk stratification, and primary prevention","volume":"129","author":"Zaman","year":"2014","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hlc.2018.08.027_bib0170","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1161\/CIRCULATIONAHA.108.836791","article-title":"Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"120","author":"Zaman","year":"2009","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.hlc.2018.08.027_bib0175","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/europace\/eus199","article-title":"Induction of ventricular tachycardia with the fourth extrastimulus and its relationship to risk of arrhythmic events in patients with post-myocardial infarct left ventricular dysfunction","volume":"14","author":"Zaman","year":"2012","journal-title":"Europace"},{"issue":"8","key":"10.1016\/j.hlc.2018.08.027_bib0180","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1161\/CIRCULATIONAHA.113.005146","article-title":"Long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction","volume":"129","author":"Zaman","year":"2014","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.hlc.2018.08.027_bib0185","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.hlc.2016.04.007","article-title":"Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator Implantation to Prevent Tachyarrhythmias following Acute Myocardial Infarction (PROTECT-ICD): trial protocol, background and significance","volume":"25","author":"Zaman","year":"2016","journal-title":"Heart Lung Circ"},{"issue":"5","key":"10.1016\/j.hlc.2018.08.027_bib0190","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/CIRCEP.113.000213","article-title":"Significance of inducible very fast ventricular tachycardia (cycle length 200\u2013230ms) after early reperfusion for ST-segment-elevation myocardial infarction","volume":"6","author":"Zaman","year":"2013","journal-title":"Circ Arrhythmia Electrophysiol"},{"issue":"18","key":"10.1016\/j.hlc.2018.08.027_bib0195","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.jacc.2013.12.021","article-title":"Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy","volume":"63","author":"Goldberger","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.hlc.2018.08.027_bib0200","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1540-8167.2010.01757.x","article-title":"Do Beta-blockers impact microvolt T-wave alternans testing in patients at risk for ventricular arrhythmias? A meta-analysis","volume":"21","author":"Chan","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"20","key":"10.1016\/j.hlc.2018.08.027_bib0205","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.jacc.2008.08.018","volume":"52","author":"Chow","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.hlc.2018.08.027_bib0210","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.jacc.2007.08.042","article-title":"Noninvasive risk assessment early after a myocardial infarction the REFINE study","volume":"50","author":"Exner","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.hlc.2018.08.027_bib0215","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1161\/01.CIR.0000117090.01718.2A","article-title":"Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification","volume":"109","author":"Camm","year":"2004","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.hlc.2018.08.027_bib0220","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1161\/CIRCULATIONAHA.106.653568","article-title":"Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction","volume":"115","author":"Schmidt","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hlc.2018.08.027_bib0225","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/CIRCIMAGING.108.826529","article-title":"Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator","volume":"2","author":"Roes","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.hlc.2018.08.027_bib0230","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/CIRCIMAGING.113.001293","article-title":"Infarct tissue heterogeneity by contrast-enhanced magnetic resonance imaging is a novel predictor of mortality in patients with chronic coronary artery disease and left ventricular dysfunction","volume":"7","author":"Watanabe","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"issue":"9","key":"10.1016\/j.hlc.2018.08.027_bib0235","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1540-8167.2009.01503.x","article-title":"Rationale and design for the Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation (DETERMINE) trial","volume":"20","author":"Kadish","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"9","key":"10.1016\/j.hlc.2018.08.027_bib0240","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2013.1363","article-title":"Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy","volume":"309","author":"Gulati","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.hlc.2018.08.027_bib0245","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/CIRCIMAGING.113.001144","article-title":"Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis","volume":"7","author":"Kuruvilla","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.hlc.2018.08.027_bib0250","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jchf.2016.09.017","article-title":"Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis","volume":"5","author":"Di Marco","year":"2017","journal-title":"JACC Heart Fail"},{"issue":"22","key":"10.1016\/j.hlc.2018.08.027_bib0255","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/CIRCULATIONAHA.116.026910","article-title":"Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction","volume":"135","author":"Halliday","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.08.027_bib0260","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.116.026910","article-title":"Association between mid-wall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction","author":"Halliday","year":"2017","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hlc.2018.08.027_bib0265","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jchf.2013.12.004","article-title":"Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure","volume":"2","author":"Ahmad","year":"2014","journal-title":"JACC Heart Fail"},{"issue":"7","key":"10.1016\/j.hlc.2018.08.027_bib0270","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.hrthm.2014.04.024","article-title":"B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias","volume":"11","author":"Levine","year":"2014","journal-title":"Heart Rhythm"},{"issue":"11","key":"10.1016\/j.hlc.2018.08.027_bib0275","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1161\/CIRCULATIONAHA.105.606145","article-title":"Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients","volume":"114","author":"Dekker","year":"2006","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.hlc.2018.08.027_bib0280","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1161\/CIRCULATIONAHA.106.624593","article-title":"Family history and the risk of sudden cardiac death as a manifestation of an acute coronary event","volume":"114","author":"Kaikkonen","year":"2006","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.hlc.2018.08.027_bib0285","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jacc.2008.06.044","article-title":"Long-term outcome and risk stratification in dilated cardiolaminopathies","volume":"52","author":"Pasotti","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.hlc.2018.08.027_bib0290","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa1510687","article-title":"A prospective study of sudden cardiac death among children and young adults","volume":"374","author":"Bagnall","year":"2016","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.hlc.2018.08.027_bib0295","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1161\/CIR.0000000000000394","article-title":"Wearable cardioverter-defibrillator therapy for the prevention of sudden cardiac death: a science advisory from the American Heart Association","volume":"133","author":"Piccini","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.08.027_bib0300","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJMoa1800781","article-title":"Wearable cardioverter\u2013defibrillator after myocardial infarction","volume":"379","author":"Olgin","year":"2018","journal-title":"N Engl J Med."}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950618319061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950618319061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:01:22Z","timestamp":1761415282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950618319061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1443950618319061"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2018.08.027","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sudden Death Risk-Stratification in 2018\u20132019: The Old and the New","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2018.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}